Valuation: Medpace Holdings, Inc.

Market Cap 17.26B 15.39B 14.25B 12.96B 24.32B 1,637B 24.72B 171B 67.23B 855B 64.77B 63.41B 2,735B P/E 2026 *
35.2x
P/E 2027 * 32.3x
Enterprise Value 16.48B 14.69B 13.61B 12.37B 23.22B 1,563B 23.6B 163B 64.19B 817B 61.84B 60.55B 2,611B EV / Sales 2026 *
5.78x
EV / Sales 2027 * 5.28x
Free-Float
81.03%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
1 week+0.16%
Current month-0.50%
1 month-0.51%
3 months+17.64%
6 months+17.52%
Current year+10.57%
1 week 605.76
Extreme 605.76
635.31
1 month 587.38
Extreme 587.385
642.64
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/12/26 Exercice

Chief Operating Officer

6,000 0.0215%
10/7/26 Exercice

Chief Operating Officer

4,000 0.0143%
9/30/26 Sell

Chief Executive Officer

-21,966 0.0787%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+0.16%+14.08%+170.53% 17.26B
+1.52%-7.16%+51.66%+67.41% 65B
+1.52%+6.83%+10.89%+79.30% 51.2B
+0.30%-0.46%-0.03%+61.89% 51.19B
-0.79%+1.00%+24.89%+41.81% 43.93B
+0.40%+5.82%+16.39%+133.69% 41.96B
+2.69%-5.63%+238.87%+531.12% 38.14B
+2.16%+10.36%+18.92%+59.70% 33.24B
-0.90%-10.49%+37.09%+1.80% 25.2B
+1.60%+2.21%+27.96%+28.00% 22.5B
Average +0.86%+0.23%+44.07%+117.52% 38.96B
Weighted average by Cap. +0.90%+0.08%+44.25%+115.28%

Financials

2026 *2027 *
Net sales 2.85B 2.54B 2.36B 2.14B 4.02B 270B 4.08B 28.25B 11.11B 141B 10.7B 10.48B 452B 3.03B 2.7B 2.5B 2.28B 4.27B 288B 4.34B 30.03B 11.81B 150B 11.38B 11.14B 480B
Net income 503M 448M 415M 377M 708M 47.66B 720M 4.98B 1.96B 24.91B 1.89B 1.85B 79.62B 546M 487M 451M 410M 770M 51.8B 782M 5.41B 2.13B 27.07B 2.05B 2.01B 86.54B
Net Debt -780M -695M -644M -586M -1.1B -73.97B -1.12B -7.73B -3.04B -38.66B -2.93B -2.87B -124B -1.24B -1.11B -1.03B -934M -1.75B -118B -1.78B -12.32B -4.84B -61.63B -4.67B -4.57B -197B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
26-10-19 US$621.04 +0.42% 79,809
26-10-16 US$618.47 -1.61% 325,148
26-10-15 US$628.60 +1.94% 391,773
26-10-14 US$616.63 +1.11% 311,258
26-10-13 US$609.89 -1.64% 155,256
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
618.47USD
Average target price
595.92USD
Spread / Average Target
-3.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock